middle.news
Island advances Galidesivir toward pivotal Marburg testing
10:32am on Tuesday 17th of November, 2026 AEDT
•
Biotechnology and Pharmaceuticals
Read Story
Island advances Galidesivir toward pivotal Marburg testing
10:32am on Tuesday 17th of November, 2026 AEDT
Key Points
Marburg dose-response study expected to begin in early December 2026
Company reported 94% survival in a treated Marburg primate model versus 0% for placebo
FDA confirmed the Animal Rule pathway and advised Galidesivir may qualify for a Tropical Disease Priority Review Voucher
Uganda MEURI program could generate prospective human safety and virological data in 2027
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Island Pharmaceuticals (ASX:ILA)
OPEN ARTICLE